The popularity of peptide therapeutics has increased significantly in recent years. Compared with chemical drugs, peptide drugs have little side-effects and little drug tolerance. Meanwhile, the specificity of treatment is high. Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated. As a result, a large number of peptide-based drugs are now being marketed. But what are peptide therapeutics and what are the main advantages and disadvantages of using them?

We wanted to share a presentation deck titled “Overcoming Drug Development Barriers for Peptide Products: Analytical, Physical and Formulation Aspects” from Tian Wu at Amgen. This talk was given during one of our previous Peptide Drug Design & Delivery Summits. This presentation gives you a brief introduction to peptide therapeutics, binding & thermal stability Issues related to Peptides, looking into Dimer and Isomerization and presenting conclusions.

Scroll through the presentation below……

 

2021 Global Drug Bioavailability Enhancement Summit

(OCT 12-13, 2021)

 

Interested to improve the performance of your drug products? Learn 2 years of new drug product development approaches at the 2021 Global Drug Bioavailability Enhancement Virtual Summit this October.

Join 100’s of leading drug delivery, formulation and development experts and hear 25+ expert sessions. Gain over 2 years worth of new drug product development strategies, formulation approaches, delivery technologies and regulatory updates while decreasing drug product time-to-market in just 2 short days (all available on-demand)!

Save over 38% on attendance registration before September 10th, 2021 (Only $309). Likewise, have a platform technology you would like to explore showcasing to the wider audience this October? Reach out below to find out remaining opportunities.

2021 On-Demand Summits Available for Purchase

(Limited time – Only $299)

Pin It on Pinterest

Share This

Share this with a friend or colleague!